Page last updated: 2024-08-25

perindoprilat and Renal Insufficiency

perindoprilat has been researched along with Renal Insufficiency in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hiromi, Y; Kato, K; Kawahara, H; Muraoka, I; Nabeshima, T; Seno, H; Takasu, R; Yamada, S	1
Aarons, L; Parker, E; Resplandy, G; Rowland, M	1
Bree, F; Nguyen, P; Resplandy, G; Tillement, JP; Urien, S	1

Trials

1 trial(s) available for perindoprilat and Renal Insufficiency

Article	Year
Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis. Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:6 Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Half-Life; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Perindopril; Quinapril; Renal Dialysis; Renal Insufficiency; Tetrahydroisoquinolines	2003

Article

Year

Elimination kinetics of quinaprilat and perindoprilat in hypertensive patients with renal failure on haemodialysis.

Biological & pharmaceutical bulletin, 2003, Volume: 26, Issue:6

Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Chromatography, High Pressure Liquid; Half-Life; Humans; Hypertension; Indoles; Male; Metabolic Clearance Rate; Middle Aged; Perindopril; Quinapril; Renal Dialysis; Renal Insufficiency; Tetrahydroisoquinolines

2003

Other Studies

2 other study(ies) available for perindoprilat and Renal Insufficiency

Article	Year
The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2005, Volume: 26, Issue:1 Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Creatinine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Models, Biological; Perindopril; Renal Insufficiency	2005
Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE. International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:9 Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Proteins; Drug Interactions; Erythrocytes; Humans; Indoles; Kinetics; Liver Failure; Peptidyl-Dipeptidase A; Perindopril; Protein Binding; Renal Insufficiency; Sensitivity and Specificity; Serum Albumin	1992

Article

Year

The pharmacokinetics of perindoprilat in normal volunteers and patients: influence of age and disease state.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2005, Volume: 26, Issue:1

Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Creatinine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Indoles; Injections, Intravenous; Male; Middle Aged; Models, Biological; Perindopril; Renal Insufficiency

2005

Specific and high affinity binding of perindoprilat, but not of perindopril to blood ACE.

International journal of clinical pharmacology, therapy, and toxicology, 1992, Volume: 30, Issue:9

Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Proteins; Drug Interactions; Erythrocytes; Humans; Indoles; Kinetics; Liver Failure; Peptidyl-Dipeptidase A; Perindopril; Protein Binding; Renal Insufficiency; Sensitivity and Specificity; Serum Albumin

1992